"Vasodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause dilation of the blood vessels.
| Descriptor ID |
D014665
|
| MeSH Number(s) |
D27.505.954.411.918
|
| Concept/Terms |
Vasodilator Agents- Vasodilator Agents
- Agents, Vasodilator
- Vasodilators
- Vasorelaxants
- Vasodilator Drugs
- Drugs, Vasodilator
|
Below are MeSH descriptors whose meaning is more general than "Vasodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasodilator Agents".
This graph shows the total number of publications written about "Vasodilator Agents" by people in this website by year, and whether "Vasodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 4 | 3 | 7 |
| 1999 | 6 | 4 | 10 |
| 2000 | 1 | 5 | 6 |
| 2001 | 3 | 3 | 6 |
| 2002 | 1 | 1 | 2 |
| 2003 | 5 | 1 | 6 |
| 2004 | 2 | 1 | 3 |
| 2005 | 3 | 1 | 4 |
| 2006 | 5 | 7 | 12 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 4 | 5 |
| 2009 | 1 | 4 | 5 |
| 2010 | 3 | 6 | 9 |
| 2011 | 4 | 1 | 5 |
| 2012 | 1 | 5 | 6 |
| 2013 | 3 | 5 | 8 |
| 2014 | 3 | 5 | 8 |
| 2015 | 5 | 4 | 9 |
| 2016 | 2 | 5 | 7 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 2 | 5 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 2 | 3 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vasodilator Agents" by people in Profiles.
-
Nicardipine Versus Nitroprusside-The Budget-Friendly Battle for Baby Blood Pressure Control. Pediatr Crit Care Med. 2024 Jun 01; 25(6):576-577.
-
The Great Masquerade: Not All Coronary Artery Stenosis Are Created Equal. Methodist Debakey Cardiovasc J. 2024; 20(1):26-32.
-
Inhaled Nitric Oxide and Higher Necrotizing Enterocolitis Rates in Congenital Heart Disease Patients. J Surg Res. 2023 08; 288:166-171.
-
Pulmonary vasodilator therapies in pulmonary arterial hypertension associated with CHD: a systematic review and network meta-analysis. Cardiol Young. 2023 Nov; 33(11):2297-2311.
-
Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT. Circulation. 2023 Jan 24; 147(4):310-323.
-
Selective Use of Pulmonary Vasodilators in Patients with Fontan Physiology. J Interv Cardiol. 2022; 2022:7602793.
-
COManeci MechANical Dilation for vasospasm (COMMAND): multicenter experience. J Neurointerv Surg. 2023 Sep; 15(9):864-870.
-
Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension. Ann Am Thorac Soc. 2022 06; 19(6):1000-1012.
-
2022 Beijing Winter Olympics: Spotlight on Cardiac Metabolism. Circulation. 2022 05 24; 145(21):1561-1562.
-
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT. J Am Heart Assoc. 2022 03 15; 11(6):e023314.